Apyx Medical Corporation (APYX) Research

Apyx Medical Corporation, an energy technology firm established in 1982 and headquartered in Clearwater, Florida, focuses on the development, manufacturing, and global sale of medical devices for both the aesthetic and surgical fields. The company operates through two main divisions: Advanced Energy and Original Equipment Manufacturing (OEM). Among its key innovations is the Helium Plasma Generator, which delivers a controlled combination of RF energy and helium to precisely cut, coagulate, and ablate soft tissue in open and laparoscopic surgical procedures. For the cosmetic surgery market, Apyx Medical offers its Renuvion product line, enabling plastic surgeons and other aesthetic practitioners to apply targeted heat for desired patient outcomes. Concurrently, the J-Plasma brand caters specifically to the hospital surgical sector. Furthermore, the company designs, produces, and sells disposable hand pieces, alongside OEM generators and their related accessories. The entity was previously known as Bovie Medical Corporation, changing its name to Apyx Medical Corporation in January 2019.

Market snapshot

Symbol
APYX
Price
$4.11
Day change
-2.38%
Market cap
$172.1M
P/E ratio
-18.90x
52-week range
1.59-5.08
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$6.00

Peer companies

  • Atossa Therapeutics, Inc. (ATOS)
  • Lucid Diagnostics Inc. (LUCD)
  • InspireMD, Inc. (NSPR)
  • Pro-Dex, Inc. (PDEX)
  • Quipt Home Medical Corp. (QIPT)
  • AVITA Medical, Inc. (RCEL)
  • Rapid Micro Biosystems, Inc. (RPID)
  • Sera Prognostics, Inc. (SERA)

Recent insider activity

  • Roman Shawn David — F-InKind (10533 shares) on 2026-06-15
  • Roman Shawn David — M-Exempt (15000 shares) on 2026-06-15
  • Roman Shawn David — M-Exempt (15000 shares) on 2026-06-15
  • Levine Wendy Lauren — A-Award (50000 shares) on 2026-06-11
  • Vizirgianakis Stavros G. — A-Award (450000 shares) on 2026-06-11

Open Apyx Medical Corporation (APYX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.